Skip to main content
. Author manuscript; available in PMC: 2010 Apr 15.
Published in final edited form as: Clin Cancer Res. 2009 Apr 7;15(8):2808–2817. doi: 10.1158/1078-0432.CCR-08-1953

Figure 2. In vitro cytotoxicity of bortezomib, dexamethasone, and doxorubicin with and without milatuzumab in CAG.

Figure 2

Cells were cultured with the drugs, milatuzumab (5 μg/ml), and GAH second antibody (20 μg/ml) as shown, then assayed using MTT. Percent inhibition of absorbance at 570 nm, relative to media only, was measured. ○, solid line, drug only; △, dashed line, drug + milatuzumab; □, dotted line, drug + GAH; ●, solid line, drug + milatuzumab + GAH. Error bars represent standard deviations of 4 replicates.